AJN supports vital research into Cystic Fibrosis
Research is absolutely critical to finding treatments and cures for any serious medical condition. Without world-class research, cures for difficult-to-treat conditions would remain elusive and many lives would be blighted.
Many of our customers and partners will already be aware that the Cystic Fibrosis Trust is a charity that is very close to AJN and we will do everything we can to support research into Cystic Fibrosis.
We have always had an excellent relationship with the Cystic Fibrosis Trust and when we heard they were forming a partnership with the University of Cambridge to create a new, world-class, research facility called ‘The Cystic Fibrosis Innovation Hub’, we were delighted to become involved and support this vital research programme.
Cystic Fibrosis is a devastating condition that affects over 10,000 people in the UK.
It is caused by a faulty gene that affects how salt and water move in and out of cells. Cystic Fibrosis is particularly harmful to the lungs and digestive system, making it hard to breathe or digest food properly.
People with the condition face hours of physiotherapy and inhaled treatments each day together with up-to fifty tablets daily to help control the condition.
A major focus for the Hub will be the development of new drugs to combat Cystic Fibrosis as well as new antibiotics to address the main causes of lung infections, which are a characteristic of the condition.
Experts hope that extensive research will result in the ability to harvest cells from a Cystic Fibrosis sufferer, re-programming them by correcting the genetic disorder and re-injecting the cells back into the patient’s body and in so doing, providing a way to regenerate damaged lungs.
AJNs contribution to the work of The Hub is significant. We are committed to finding a cure for this terrible condition, and we are proud to be associated with the new Hub.
Commenting on our involvement, Anne Shinkwin, Director of Fundraising, said: “The Cystic Fibrosis Trust is very appreciative of the early support and substantial financial contribution from AJN for the Innovation Hub.
“The support has enabled this very important partnership with the University of Cambridge for Cystic Fibrosis research to commence at the start of this year.”